Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,614,203
-
Share change
-
+298,666
-
Total reported value
-
$520,722,899
-
Put/Call ratio
-
19%
-
Price per share
-
$17.01
-
Number of holders
-
111
-
Value change
-
-$2,803,008
-
Number of buys
-
62
-
Number of sells
-
52
Institutional Holders of INTERSECT ENT INC - COM (XENT) as of Q3 2019
As of 30 Sep 2019,
INTERSECT ENT INC - COM (XENT) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,614,203 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), HealthCor Management, L.P., BlackRock Inc., Point72 Asset Management, L.P., VANGUARD GROUP INC, UBS Group AG, First Light Asset Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, WESTFIELD CAPITAL MANAGEMENT CO LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
111
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.